Showing results (341-350 of 811) with videos related to
Sort By:
Pageof 82
Endoscopy|October 10, 2025
Time trends in post-polypectomy surveillance guideline adherence: analysis of over 90 000 colonoscopies with polypectomyJasmin Zessner-Spitzenberg, Daniela Penz, Elisabeth Waldmann, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 16, 2018
High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitisMichael Eder, Robert Strassl, Sandra Beinhardt, et al.Wiener Klinische Wochenschrift|September 8, 2019
Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver diseaseLukas W Unger, Bernadette Forstner, Stephan Schneglberger, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implicationsKatharina Staufer, Kevin Roedl, Danijel Kivaranovic, et al.Hepatology (Baltimore, Md.)|January 15, 2013
The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinomaWolfgang Sieghart, Florian Hucke, Matthias Pinter, et al.Hepatology (Baltimore, Md.)|May 12, 2012
Common genetic variation in vitamin D metabolism is associated with liver stiffnessFrank Grünhage, Katrin Hochrath, Marcin Krawczyk, et al.Journal of Hepatology|April 26, 2024
Assessment of fatigue and its impact in chronic liver diseaseZobair M Younossi, Andreas E Kremer, Mark G Swain, et al.Alimentary Pharmacology & Therapeutics|May 27, 2024
Portal hypertension and its prognostic implications in patients with Wilson's diseaseLukas Burghart, Peter Ferenci, Oleksandr Petrenko, et al.Nutrients|September 10, 2020
Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control StudyAndreas Blesl, Christoph Jüngst, Frank Lammert, et al.European Journal of Cancer (Oxford, England : 1990)|July 18, 2017
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factorsNicole Golob-Schwarzl, Stefanie Krassnig, Anna M Toeglhofer, et al.Pageof 82